Assessing the Current in Engineered Rodent Models of GBM to Align with Regulatory Requirements
11:30 am - Thursday 19th February 2026
- Evaluating the utility of genetically engineered mouse models, xenograft cell lines, and syngeneic models to determine their relevance and effectiveness in glioblastoma research
- Learning how to use these advanced models to accurately simulate the glioblastoma microenvironment and enhance the effectiveness of preclinical drug testing
- Identifying the most suitable modelling approaches for ensuring that preclinical findings are reliable and can be successfully translates into clinical applications
